A new report titled “Pharmaceuticals Wholesale and Distribution Market – Forecast to 2032” by Eternal Market, the global pharmaceuticals wholesale and distribution industry is projected to grow at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2032. Market size is expected to increase by US$ 769.5 billion by the forecast period.
Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Wholesale distributors are responsible for guaranteeing product quality and preventing the influx of counterfeit drugs. Pharmaceutical companies have assigned distributors and wholesalers to create a more efficient distribution channel. Pharmaceutical distributors are mainly work-specific and tend to specify terms and conditions. Wholesalers are more in contact with distributors and, rarely, with the company; they buy drugs and medicines in bulk and resell them at a higher price. The wholesalers’ representatives go to the retailers for subsequent sales that are in contact with consumers.
Growing global pharmaceutical sales are largely contributing to the growth of the market.
Prescription and over-the-counter medications are included in the pharmaceutical market, which is anticipated to develop significantly throughout the forecast period. The main drivers of market expansion are the rising elderly population and new product launches by pharmaceutical companies. The prevalence of chronic diseases and the demand for better medical care are both on the rise. A greater requirement for more sophisticated equipment is urgently needed to adequately manage the expanding patient population. As a result, innovative medical equipment and practical transportation options for healthcare equipment have been developed.
The healthcare industry worldwide has grown significantly in recent years as a result of an ageing population and a significant increase in spending that is subsidized through programs such as Medicare and Medicaid. Healthcare mergers and acquisitions have reached new highs, and for the first time, healthcare jobs have surpassed retail and manufacturing jobs.
Along with that, in order to get pharmaceutical supplies to different areas, the wholesale and distribution of pharmaceuticals heavily relies on the trucking industry. The global logistics business does, however, confront a professional truck driver shortage, which might disrupt supply chains. The global market is expanding as a result of rising demand for pharmaceutical supplies, but in developing nations such as Vietnam, where logistical infrastructure is weak, it is difficult to distribute pharmaceutical products. Throughout the projection period, the market would be impacted by the widening supply-demand mismatch for qualified truck drivers.
Pharma and IT companies have a huge market opportunity.
The volume of information produced in any healthcare facility or division can be staggering. Without a strategy plan, businesses may not be able to collect, integrate, and evaluate the data they need to identify trends and take advantage of opportunities. Analytics should be prioritized since hospitals spend almost a third of their operating budgets managing the supply chain. A multidisciplinary team of medical professionals, IT experts, and support staff members should be consulted to define agreed-upon goals. Businesses can give the group the authority to look beyond their own data sets and focus instead on how information from their immediate area of influence fits into the overall picture. This is essential, as supply chains consist of many interdependent layers, including suppliers, pricing tiers, medical supplies, drugs, and so on.
Add on to this, one major driver propelling the expansion of the pharmaceutical wholesaler and distribution industry is the increase in seaborne pharmaceutical transportation. This is a result of the fuel expenses associated with land and air travel, the carbon emissions produced in the process, as well as other elements including security and environmental sustainability. The market for pharmaceutical distribution and wholesale has grown as a result.
The global Pharmaceuticals Wholesale and Distribution market is segmented based on Type (Branded Drugs and Generic Drugs), and End-User (Retail Pharmacies, Hospital Pharmacies, and Other End Users)
Based on type, the branded drugs segment will have significant market share growth during the forecast period. Branded drugs are discovered and developed by pharmaceutical companies based on extensive research and development (R&D). The drugs are approved by the United States Food and Drug Administration (FDA) based on the information provided by the pharmaceutical company on their dosage form, chemistry, safety, efficacy, manufacturing methodology, labelling, and packaging.
Key players operating in the global Pharmaceuticals Wholesale and Distribution market include Alfresa Holdings, AmerisourceBergen Corporation, Cardinal Health Inc., China Resources Pharmaceutical Group Limited, CuraScript SD, Dakota Drug Inc., Fortissa, Fosun International, Geo-Young Corporation, Kingworld Medicines Group Ltd., Mawdsley-Brooks, McKesson Corporation, Medipal Holdings Corporation, Morris and Dickson, Mutual Drug Company, Ohki Healthcare Holdings Co. Ltd, Petrone Group, PHOENIX Group, Prodigy Health among others.
Recent Developments:
On Apr 2022: In April 2022, with the opening of 12 new Walgreens Health CornerTM sites in the San Francisco Bay Area and Los Angeles County, Blue Shield of California and Walgreens Health will increase access to in-person and virtual care options.
On Apr 2022: In April 2022, AmerisourceBergen (AB) announced its partnership with Chronicled to leverage a new block chain-powered solution designed to enhance pharmaceutical chargeback accuracy and significantly reduce chargeback rejections.
Major Strategies adopted by key market players
- Agreements, Collaborations, and Partnerships: XX%
- Acquisitions: XX%
- New Product Launch: XX%
- Other Developments: XX%
Scope of the Report:
Global Pharmaceuticals Wholesale and Distribution Market, by Type
- Branded Drugs
- Generic Drugs
Global Pharmaceuticals Wholesale and Distribution Market, by End Users
- Retail Pharmacies
- Hospital Pharmacies
- Other End Users
Global Blenders for smoothies Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
-
- Brazil
- Argentina
- Rest of South America
-
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
Alfresa Holdings
AmerisourceBergen Corporation
Cardinal Health Inc.
China Resources Pharmaceutical Group Limited
CuraScript SD
Dakota Drug Inc.
Fortissa
Fosun International
Geo-Young Corporation
Kingworld Medicines Group Ltd.
Other Companies
*The report scope shall be customized as per the requirements
Chapter 1 Global Pharmaceuticals Wholesale and Distribution Market Overview
1.1 Introduction
1.2 Drivers for Pharmaceuticals Wholesale and Distribution Market
1.3 Restraints for Pharmaceuticals Wholesale and Distribution Market
1.4 Opportunities for Pharmaceuticals Wholesale and Distribution Market
1.5 Trends for Pharmaceuticals Wholesale and Distribution Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Pharmaceuticals Wholesale and Distribution Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Alfresa Holdings
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 AmerisourceBergen Corporation
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Cardinal Health Inc.
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 China Resources Pharmaceutical Group Limited
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 CuraScript SD
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Dakota Drug Inc.
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Fortissa
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Fosun International
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Geo-Young Corporation
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Kingworld Medicines Group Ltd.
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Pharmaceuticals Wholesale and Distribution Market Overview
3.1 Global Pharmaceuticals Wholesale and Distribution Market Outlook (2017-2032)
3.1.1 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2017-2023)
3.1.2 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2024-2032)
3.2 Global Pharmaceuticals Wholesale and Distribution Market by Region
3.2.1 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2032)
3.2.2 Global Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Pharmaceuticals Wholesale and Distribution Market by Type
3.3.1 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2032)
3.3.2 Global Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Type, 2023–2032
3.3.3 Global Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Pharmaceuticals Wholesale and Distribution Market by End Users
3.4.1 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2032)
3.4.2 Global Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by End Users, 2023–2032
3.5 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Region
3.5.1 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2023)
3.5.2 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2024-2032)
3.6 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Type
3.6.1 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2023)
3.6.2 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2024-2032)
3.7 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by End Users
3.7.1 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2023)
3.7.2 Global Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2024-2032)
3.8 Global Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Region
3.8.2 Global Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Type
3.8.3 Global Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by End Users
3.9 Global Pharmaceuticals Wholesale and Distribution Market Share Comparison 2017–2032
3.9.1 Global Pharmaceuticals Wholesale and Distribution Market Share by Region
3.9.2 Global Pharmaceuticals Wholesale and Distribution Market Share by Type
3.9.3 Global Pharmaceuticals Wholesale and Distribution Market Share by End Users
Chapter 4 North America Pharmaceuticals Wholesale and Distribution Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Pharmaceuticals Wholesale and Distribution Market Outlook (2017-2032)
4.2.1 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2017-2023)
4.2.2 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2024-2032)
4.3 North America Pharmaceuticals Wholesale and Distribution Market by Region
4.3.1 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2032)
4.3.2 North America Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Pharmaceuticals Wholesale and Distribution Market by Type
4.4.1 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2032)
4.4.2 North America Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Type, 2023–2032
4.4.3 North America Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Pharmaceuticals Wholesale and Distribution Market by End Users
4.5.1 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2032)
4.5.2 North America Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by End Users, 2023–2032
4.6 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Region
4.6.1 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2023)
4.6.2 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2024-2032)
4.7 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Type
4.7.1 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2023)
4.7.2 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2024-2032)
4.8 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by End Users
4.8.1 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2023)
4.8.2 North America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2024-2032)
4.9 North America Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Region
4.9.2 North America Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Type
4.9.3 North America Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by End Users
4.1 North America Pharmaceuticals Wholesale and Distribution Market Share Comparison 2017–2032
4.10.1 North America Pharmaceuticals Wholesale and Distribution Market Share by Region
4.10.2 North America Pharmaceuticals Wholesale and Distribution Market Share by Type
4.10.3 North America Pharmaceuticals Wholesale and Distribution Market Share by End Users
Chapter 5 Europe Pharmaceuticals Wholesale and Distribution Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Pharmaceuticals Wholesale and Distribution Market Outlook (2017-2032)
5.2.1 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2017-2023)
5.2.2 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2024-2032)
5.3 Europe Pharmaceuticals Wholesale and Distribution Market by Region
5.3.1 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2032)
5.3.2 Europe Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Pharmaceuticals Wholesale and Distribution Market by Type
5.4.1 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2032)
5.4.2 Europe Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Type, 2023–2032
5.4.3 Europe Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Pharmaceuticals Wholesale and Distribution Market by End Users
5.5.1 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2032)
5.5.2 Europe Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by End Users, 2023–2032
5.6 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Region
5.6.1 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2023)
5.6.2 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2024-2032)
5.7 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Type
5.7.1 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2023)
5.7.2 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2024-2032)
5.8 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by End Users
5.8.1 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2023)
5.8.2 Europe Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2024-2032)
5.9 Europe Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Region
5.9.2 Europe Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Type
5.9.3 Europe Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by End Users
5.1 Europe Pharmaceuticals Wholesale and Distribution Market Share Comparison 2017–2032
5.10.1 Europe Pharmaceuticals Wholesale and Distribution Market Share by Region
5.10.2 Europe Pharmaceuticals Wholesale and Distribution Market Share by Type
5.10.3 Europe Pharmaceuticals Wholesale and Distribution Market Share by End Users
Chapter 6 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Outlook (2017-2032)
6.2.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2017-2023)
6.2.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2024-2032)
6.3 Asia Pacific Pharmaceuticals Wholesale and Distribution Market by Region
6.3.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Pharmaceuticals Wholesale and Distribution Market by Type
6.4.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2032)
6.4.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Type, 2023–2032
6.4.3 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Pharmaceuticals Wholesale and Distribution Market by End Users
6.5.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2032)
6.5.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by End Users, 2023–2032
6.6 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Region
6.6.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2024-2032)
6.7 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Type
6.7.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2023)
6.7.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2024-2032)
6.8 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by End Users
6.8.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2023)
6.8.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2024-2032)
6.9 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Type
6.9.3 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by End Users
6.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Share Comparison 2017–2032
6.10.1 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Share by Region
6.10.2 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Share by Type
6.10.3 Asia Pacific Pharmaceuticals Wholesale and Distribution Market Share by End Users
Chapter 7 South America Pharmaceuticals Wholesale and Distribution Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Pharmaceuticals Wholesale and Distribution Market Outlook (2017-2032)
7.2.1 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2017-2023)
7.2.2 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2024-2032)
7.3 South America Pharmaceuticals Wholesale and Distribution Market by Region
7.3.1 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2032)
7.3.2 South America Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Pharmaceuticals Wholesale and Distribution Market by Type
7.4.1 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2032)
7.4.2 South America Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Type, 2023–2032
7.4.3 South America Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Pharmaceuticals Wholesale and Distribution Market by End Users
7.5.1 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2032)
7.5.2 South America Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by End Users, 2023–2032
7.6 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Region
7.6.1 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2023)
7.6.2 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2024-2032)
7.7 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Type
7.7.1 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2023)
7.7.2 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2024-2032)
7.8 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by End Users
7.8.1 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2023)
7.8.2 South America Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2024-2032)
7.9 South America Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Region
7.9.2 South America Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Type
7.9.3 South America Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by End Users
7.1 South America Pharmaceuticals Wholesale and Distribution Market Share Comparison 2017–2032
7.10.1 South America Pharmaceuticals Wholesale and Distribution Market Share by Region
7.10.2 South America Pharmaceuticals Wholesale and Distribution Market Share by Type
7.10.3 South America Pharmaceuticals Wholesale and Distribution Market Share by End Users
Chapter 8 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Outlook (2017-2032)
8.2.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2017-2023)
8.2.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) (2024-2032)
8.3 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market by Region
8.3.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market by Type
8.4.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2032)
8.4.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Type, 2023–2032
8.4.3 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market by End Users
8.5.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2032)
8.5.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Attractiveness Analysis by End Users, 2023–2032
8.6 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Region
8.6.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Region (2024-2032)
8.7 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by Type
8.7.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2017-2023)
8.7.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by Type (2024-2032)
8.8 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) by End Users
8.8.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2017-2023)
8.8.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Value (US$ Mn) Comparison by End Users (2024-2032)
8.9 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by Type
8.9.3 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Y-o-Y Growth Rate by End Users
8.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Share by Region
8.10.2 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Share by Type
8.10.3 Middle East and Africa Pharmaceuticals Wholesale and Distribution Market Share by End Users
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources